PetMed Express Valuation
| PQM Stock | EUR 4.20 0.17 3.89% |
At this time, the company appears to be fairly valued. PetMed Express holds a recent Real Value of €4.13 per share. The prevailing price of the company is €4.2. Our model determines the value of PetMed Express from analyzing the company fundamentals such as Return On Equity of 0.0831, shares outstanding of 21.08 M, and Operating Margin of 0.05 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that PetMed Express' price fluctuation is risky at this time. Calculation of the real value of PetMed Express is based on 3 months time horizon. Increasing PetMed Express' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PetMed stock is determined by what a typical buyer is willing to pay for full or partial control of PetMed Express. Since PetMed Express is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PetMed Stock. However, PetMed Express' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.2 | Real 4.13 | Hype 4.2 | Naive 3.86 |
The real value of PetMed Stock, also known as its intrinsic value, is the underlying worth of PetMed Express Company, which is reflected in its stock price. It is based on PetMed Express' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of PetMed Express' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of PetMed Express helps investors to forecast how PetMed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PetMed Express more accurately as focusing exclusively on PetMed Express' fundamentals will not take into account other important factors: PetMed Express Total Value Analysis
PetMed Express is at this time estimated to have takeover price of 290.33 M with market capitalization of 367.6 M, debt of 0, and cash on hands of 100.53 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the PetMed Express fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
290.33 M | 367.6 M | 0 | 100.53 M |
PetMed Express Investor Information
About 83.0% of the company shares are owned by institutional investors. The book value of PetMed Express was at this time reported as 6.57. The company last dividend was issued on the 16th of February 2023. Based on the key indicators related to PetMed Express' liquidity, profitability, solvency, and operating efficiencyBased on the analysis of, PetMed Express is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.PetMed Express Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. PetMed Express has an asset utilization ratio of 155.07 percent. This implies that the Company is making €1.55 for each dollar of assets. An increasing asset utilization means that PetMed Express is more efficient with each dollar of assets it utilizes for everyday operations.PetMed Express Ownership Allocation
PetMed Express owns a total of 21.08 Million outstanding shares. The majority of PetMed Express outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in PetMed Express to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in PetMed Express. Please pay attention to any change in the institutional holdings of PetMed Express as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.PetMed Express Profitability Analysis
The company reported the revenue of 273.42 M. Net Income was 21.1 M with profit before overhead, payroll, taxes, and interest of 78.08 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PetMed Express' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PetMed Express and how it compares across the competition.
About PetMed Express Valuation
The stock valuation mechanism determines PetMed Express' current worth on a weekly basis. Our valuation model uses a comparative analysis of PetMed Express. We calculate exposure to PetMed Express's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PetMed Express's related companies.PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida. PetMed Express is traded on Frankfurt Stock Exchange in Germany.
8 Steps to conduct PetMed Express' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates PetMed Express' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct PetMed Express' valuation analysis, follow these 8 steps:- Gather financial information: Obtain PetMed Express' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine PetMed Express' revenue streams: Identify PetMed Express' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research PetMed Express' industry and market trends, including the size of the market, growth rate, and competition.
- Establish PetMed Express' growth potential: Evaluate PetMed Express' management, business model, and growth potential.
- Determine PetMed Express' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate PetMed Express' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for PetMed Stock analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges |